No Detail Found!

Investigating cytokine responses in rats: Genetic immunization against tuberculosis using five Mycobacterium tuberculosis-specific genes

Author(s)
Muhammad Mohsin Zaman Department of Biochemistry & Molecular Biology, Institute of Biochemistry, Biotechnology & Bioinformatics, The Islamia University of Bahawalpur, Pakistan
Mirza Imran Shahzad Department of Biochemistry & Molecular Biology, Institute of Biochemistry, Biotechnology & Bioinformatics, The Islamia University of Bahawalpur, Pakistan
Gildardo Rivera Instituto Politécnico Nacional Centro de Biotecnología Genomica Mexico City,DF,Mexico
Aeman Jilani Department of Biochemistry & Molecular Biology, Institute of Biochemistry, Biotechnology & Bioinformatics, The Islamia University of Bahawalpur, Pakistan
Areeba Yousaf Department of Biochemistry & Molecular Biology, Institute of Biochemistry, Biotechnology & Bioinformatics, The Islamia University of Bahawalpur, Pakistan
Abstract
Tuberculosis, being an infectious disease, is unchecked and still hard to wipe out in the underdeveloped countries. Despite ongoing efforts, no new TB vaccine has been successfully developed in the past century beyond BCG, although DNA-based vaccines have shown promise over the last two decades. In this study, five Mycobacterium tuberculosis-specific genes- Rv1908c/KatG, Rv3418c/GroES, Rv0934/PhoS1/PstS, Rv0440/GroEL2 and Rv0350/DnaKwere cloned into the pVAX1 expression vector to construct DNA vaccines. These constructs were evaluated in rats using naked DNA and BCG prime-boost strategies. Forty-five Wistar albino rats were divided into three major groups: DNA vaccine group, BCG prime-boost group and no vaccine control. Post-immunization responses were evaluated through cytokine ELISA for TNF-a, IFN-? and IL-6. Among DNA vaccines, DnaK-pVAX1 and GroES-pVAX1 elicited the strongest cytokine responses, followed by GroEL2-pVAX1 and PstS-pVAX1. The prime-boost groups (especially BCG + DnaK-pVAX1, BCG + GroES-pVAX1 and BCG + cocktail) showed further enhanced responses. Statistical analysis confirmed significant cytokine elevation in vaccinated groups compared to controls (p < 0.05). DNA vaccines, whether used alone or in combination with BCG, show strong potential as immunogenic and therapeutic tools for TB and may help reduce treatment duration in the future.
Publication Details
Page(s) 2271-2278
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Interleukin-6 (IL-6), Tumor necrosis factor-alpha (TNF-a), Mycobacterium tuberculosis, DNA vaccine, Interferon-gamma (IFN-y), pVAX1, Bacille Calmette-Guérin (BCG)
References
Abebe F and Bjune G .2009 .The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol., 157(2) : 235-243.
Adepoju VA,Onyezue OI .2023 .Ending the TB pandemic: The urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council. , 19(3) : 230036.
Boni FG,Hamdi I,Koundi LM,Shrestha K,Xie J .2022 .Cytokine storm in tuberculosis and IL-6 involvement. Infect. Genet, 97 : 105166.
Bulut Y,Michelsen KS,Hayrapetian L,Naiki Y,Spallek R,Singh M,Arditi M M .2005 .Mycobacterium tuberculosis heat shock proteins use diverse toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem, 280(22) : 20961-20967.
Cavalcanti YVN,Brelaz MCA,Neves JKDAL,Ferraz JC,Pereira VRA .2012 .Role of TNF-alpha, IFNgamma, and IL-10 in the development of pulmonary tuberculosis. Pulm. Med, : .
Chandrashekara S,Anupama K,Sambarey A,Chandra N A .2016 .High IL-6 and low IL-15 levels mark the presence of TB infection: A preliminary study. Cytokine, 81 : 57-62.
Cords O,Martinez L,Warren JL,O'marr JM,Walter KS,Cohen T,Zheng J,Ko AI,Croda J,Andrews JR .2021 .Incidence and prevalence of tuberculosis in incarcerated populations: A systematic review and meta-analysis. Lancet Public Health, 6(5) : e300-e308.
Esparza M,Palomares B,García T,Espinosa P,Zenteno E,Mancilla R .2015 .PstS‐1, the 38‐kDa Mycobacterium tuberculosis glycoprotein, is an adhesin, which binds the macrophage mannose receptor and promotes phagocytosis. Scand. J. Immunol., 81(1) : 46-55.
Fan M,Rao T,Zacco E,Ahmed MT,Shukla A,Ojha A,Freeke J,Robinson CV,Benesch JL,Lund PA .2012 .The unusual mycobacterial chaperonins: Evidence for in vivo oligomerization and specialization of function. Mol. Microbiol, 85(5) : 934-944.
Fan X,Li X,Wan K,Zhao X,Deng Y,Chen Z,Luan X,Lu S,Liu H S .2021 .Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis. Vaccine, 39(47) : 6860-6865.
Kumar P .2021 .A perspective on the success and failure of BCG. , 12 : 778028.
Li X,Xiao T,Li M,Liu H,Li S,Luo Q,Lou Y,Wan K Y,Microbiol Y .2019 .Evaluation of the antigenicity of Dnak and MPT83 proteins of Mycobacterium tuberculosis. , : 106-113.
Liang Y,Li X,Yang Y,Xiao L,Liang Y,Mi J,Xue Y,Gong W,Wang L,Wang J .2023 .Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection. Front. Immunol., 14 : 1110843.
Lobue P,Enarson D,Thoen T .2010 .Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States [Serialised article. Tuberculosis: A re-emerging disease in animals and humans. Number 2 in the series]. Int. J. Tuberc. Lung. Dis., 14 : 1226-1232.
Lopes RL,Borges TJ,Araújo JF,Pinho NG,Bergamin L S,Battastini AMO,Muraro SP,Souza APD,Zanin RF,Bonorino C .2014 .Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotype. PLoS One, 9(11) : e113441.
Maurya VK,Singh K,Sinha S K .2014 .Suppression of Eis and expression of Wag31 and GroES in Mycobacterium tuberculosis cytosol under anaerobic culture conditions Indian J. , 52(8) : 773-780.
Moorlag SJ,Taks E,Ten Doesschate T,Van Der Vaart TW,Janssen AB,Muller L,Ostermann P,Dijkstra H,Lemmers H,Simonetti E .2022 .Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic. Clin. Infect. Dis., 75(1) : e938-e946.
Natarajan A,Beena P,Devnikar AV,Mali S AV .2020 .A systemic review on tuberculosis. Indian J. Tuberc., 67(3) : 295-311.
Ng VH,Cox JS,Sousa AO,Macmicking JD,Mckinney JD .2004 .Role of KatG catalase‐peroxidase in mycobacterial pathogenesis: Countering the phagocyte oxidative burst. Mol. Microbiol, 52(5) : 1291-1302.
Ofori-Anyinam N,Hamblin M,Coldren ML,Li B,Mereddy G,Shaikh M,Shah A,Ranu N,Lu S,Blainey PC .2023 .KatG catalase deficiency confers bedaquiline hyper-susceptibility to isoniazid resistant Mycobacterium tuberculosis. , 10 : .
Organization WH .2023 .. Global tuberculosis report 2023, : .
Palma C,Schiavoni G,Abalsamo L,Mattei F,Piccaro G,Sanchez M,Fernandez C,Singh M,Gabriele L M .2013 .M ycobacterium tuberculosis P st S 1 amplifies IFN‐γ and induces IL‐17/IL‐22 responses by unrelated memory CD 4+ T cells via dendritic cell activation. Eur. J. Immunol., 43(9) : 2386-2397.
Qamra R,Srinivas V,Mande SC .2004 .Mycobacterium tuberculosis GroEL homologues unusually exist as lower oligomers and retain the ability to suppress aggregation of substrate proteins. J. Mol. Biol, 342(2) : 605-617.
Sachdeva KS,Chadha VK .2024 .TB-vaccines: Current status & challenges. Indian J. Med. Res., 160(3- 4) : 338.
Safar HA,Mustafa AS,Amoudy HA,El-Hashim A .2020 .The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins. PLoS One, 15(2) : e0228381.
Salari N,Kanjoori AH,Hosseinian-Far A,Hasheminezhad R,Mansouri K,Mohammadi M K .2023 .Global prevalence of drug-resistant tuberculosis: A systematic review and meta-analysis. Infect. Dis. Poverty, 12(1) : 57.
Srivastava S,Dey S,Mukhopadhyay S S .2023 .Vaccines against tuberculosis: Where are we now?. Vaccines, 11(5) : 1013.
Vinod V,Pushkaran AC,Kumar A,Mohan CG,Biswas R .1865 .Interaction mechanism of Mycobacterium tuberculosis GroEL2 protein with macrophage Lectinlike, oxidized low-density lipoprotein receptor-1: An integrated computational and experimental study. Biochim. Biophys. Acta Gen, : 129758.
Wang N,Liang Y,Ma Q,Mi J,Xue Y,Yang Y,Wang L,Wu X .2023 .Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury. Immun. Inflamm. Dis., 11(5) : e854.
Whitlow E,Mustafa AS,Hanif SNM .2020 .An overview of the development of new vaccines for tuberculosis. Vaccines, 8(4) : 586.
Wilkie ME,Mcshane H .2015 .TB vaccine development: Where are we and why is it so difficult?. Thorax, 70(3) : 299-301.
Zaman MM,Shahzad MI,Jilani A,Yousaf A,Bashir A,Riaz S,Rivera G .2024 .Construction of subunitbased DNA vaccines against tuberculosis using five different Mycobacterium specific genes. Adv. Life Sci, 11 : 585-592.
Zhuang L,Ye Z,Li L,Yang L,Gong W .2023 .Nextgeneration TB vaccines: Progress, challenges and prospects. Vaccines, 11(8) : 1304.
0

Citations

0

Downloads

55

Views